Myelodysplastic Syndrome

MD IQ

News

HIF1A could be therapeutic target for MDS

The transcription factor HIF1A could be a therapeutic target for “a broad spectrum” of patients with myelodysplastic syndromes (MDS), according to...

News

Familial risk of myeloid malignancies

A large study has revealed “the strongest evidence yet” supporting genetic susceptibility to myeloid malignancies, according to a researcher. The...

Pages